Ignite Creation Date:
2024-05-06 @ 8:13 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02693015
Status:
COMPLETED
Last Update Posted:
2016-02-26
First Post:
2016-02-23
Brief Title:
Impact of Time to Coronary Angiography on Survival for NSTEMI
Sponsor:
University of Leeds
Organization:
University of Leeds
Study Overview
Official Title:
Impact of Time to Coronary Angiography on Survival for NSTEMI an Observation Study Using a Nationwide Registry
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the extent to which the time to angiography impacts on survival in patients hospitalised with NSTEMI
Detailed Description:
The use of an invasive strategy for the management of NSTEMI according to estimated risk of 6 month mortality is recommended by international guidelines NSTEMI appropriate for coronary angiography and percutaneous intervention have better outcomes compare with NSTEMI who are medically managed Whilst the national and international guidelines recommend that the timing of in-hospital coronary angiography 24 24-72 72-96 and 96 hours is based upon estimated clinical risk using the GRACE risk score there is scientific and clinical uncertainty as to the incremental benefit that more urgent invasive treatments strategies have over and above that of delayed strategies Moreover the investigators recent research has shown that in the UK may NSTEMI eligible for coronary angiography fail to achieve care according to the recommended time thresholds and this is associated with potentially avoidable premature death
This study aims to investigate the extent to which the time to angiography impacts on survival in patients hospitalised with NSTEMI It will characterise patients according to their estimated risk of death their time to angiography and associated outcomes The investigators anticipate that this observational study will provide Level B evidence for the benefits of the timing of an invasive strategy according to the GRACE risk score The investigators are aware that the NICE guidelines for the management of acute chest pain are to be updated in 2016
This study aims to investigate the extent to which the time to angiography impacts on survival in patients hospitalised with NSTEMI It will characterise patients according to their estimated risk of death their time to angiography and associated outcomes The investigators anticipate that this observational study will provide Level B evidence for the benefits of the timing of an invasive strategy according to the GRACE risk score The investigators are aware that the NICE guidelines for the management of acute chest pain are to be updated in 2016
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None